Global Anxiety Disorders & Depression Treatment Market to reach USD 18.94 billion by 2027.

Global Anxiety Disorders & Depression Treatment Market Size study, by Product (Antidepressant Drugs and Therapy & Devices), by Indication (MDD, OCD, Phobia and Others), and Regional Forecasts 2021-2027
Product Code:  HALDAT_25725547
 Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1.	Anxiety Disorders & Depression Treatment Market, by Product, 2019-2027 (USD Billion)
1.2.2.	Anxiety Disorders & Depression Treatment Market, by Indication, 2019-2027 (USD Billion)
1.2.3.	Anxiety Disorders & Depression Treatment Market, by region, 2019-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Anxiety Disorders & Depression Treatment Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Anxiety Disorders & Depression Treatment Market Dynamics	
3.1.	Anxiety Disorders & Depression Treatment Market Impact Analysis (2019-2027)
3.1.1.	Market Drivers
3.1.1.1.	Increasing population with anxiety and depression disorders
3.1.1.2.	Growing awareness for mental disorders
3.1.2.	Market Challenges
3.1.2.1.	Expiration of patents of depression and anxiety medications
3.1.3.	Market Opportunities
3.1.3.1.	Governmental initiatives to tackle mental health
Chapter 4.	Global Anxiety Disorders & Depression Treatment Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Anxiety Disorders & Depression Treatment Market, by Product
5.1.	Market Snapshot 
5.2.	Global Anxiety Disorders & Depression Treatment Market by Product, Performance - Potential Analysis
5.3.	Global Anxiety Disorders & Depression Treatment Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4.	Anxiety Disorders & Depression Treatment Market, Sub Segment Analysis
5.4.1.	Antidepressant Drugs
5.4.2.	Therapy & Devices
Chapter 6.	Global Anxiety Disorders & Depression Treatment Market, by Indication
6.1.	Market Snapshot 
6.2.	Global Anxiety Disorders & Depression Treatment Market by Indication, Performance - Potential Analysis
6.3.	Global Anxiety Disorders & Depression Treatment Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
6.4.	Anxiety Disorders & Depression Treatment Market, Sub Segment Analysis
6.4.1.	Major Depressive Disorder (MDD)
6.4.2.	Obsessive-Compulsive Disorder (OCD)
6.4.3.	Phobia
6.4.4.	Others
Chapter 7.	Global Anxiety Disorders & Depression Treatment Market, Regional Analysis
7.1.	Anxiety Disorders & Depression Treatment Market, Regional Market Snapshot 
7.2.	North America Anxiety Disorders & Depression Treatment Market 
7.2.1.	U.S. Anxiety Disorders & Depression Treatment Market
7.2.1.1.	Product breakdown estimates & forecasts, 2018-2027 
7.2.1.2.	Indication breakdown estimates & forecasts, 2018-2027
7.2.2.	Canada Anxiety Disorders & Depression Treatment Market
7.3.	Europe Anxiety Disorders & Depression Treatment Market Snapshot
7.3.1.	U.K. Anxiety Disorders & Depression Treatment Market 
7.3.2.	Germany Anxiety Disorders & Depression Treatment Market
7.3.3.	France Anxiety Disorders & Depression Treatment Market
7.3.4.	Spain Anxiety Disorders & Depression Treatment Market
7.3.5.	Italy Anxiety Disorders & Depression Treatment Market
7.3.6.	Rest of Europe Anxiety Disorders & Depression Treatment Market
7.4.	Asia-Pacific Anxiety Disorders & Depression Treatment Market Snapshot
7.4.1.	China Anxiety Disorders & Depression Treatment Market 
7.4.2.	India Anxiety Disorders & Depression Treatment Market 
7.4.3.	Japan Anxiety Disorders & Depression Treatment Market
7.4.4.	Australia Anxiety Disorders & Depression Treatment Market
7.4.5.	South Korea Anxiety Disorders & Depression Treatment Market
7.4.6.	Rest of Asia Pacific Anxiety Disorders & Depression Treatment Market
7.5.	Latin America Anxiety Disorders & Depression Treatment Market Snapshot
7.5.1.	Brazil Anxiety Disorders & Depression Treatment Market
7.5.2.	Mexico Anxiety Disorders & Depression Treatment Market
7.6.	Rest of The World Anxiety Disorders & Depression Treatment Market
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	  Pfizer Inc
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	  GlaxoSmithKline
8.2.3.	Merck & Co. Inc
8.2.4.	AstraZeneca
8.2.5.	Eli Lily & Co
8.2.6.	Johnson & Johnson
8.2.7.	Forest Laboratories, Inc
8.2.8.	Sanofi-Aventis
8.2.9.	H. Lundbeck A/S
8.2.10.	Bristol-Myers Squibb Company
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Anxiety Disorders & Depression Treatment Market is valued approximately USD 16.66 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.85% over the forecast period 2021-2027. Anxiety and Depression are classified as a mood disorders symptoms of which include feelings of sadness, loss, or anger that interfere with a person’s everyday activities. Major Depressive Disorder, Persistent depressive disorder and Premenstrual dysphoric disorder are some commonly occurring types of depression. After the COVID-19 pandemic, there is the sudden upsurge of mental health related disorders due to the grim atmosphere around, social distancing and loneliness. The rise in cases of depression and anxiety disorders, coupled with the increasing awareness for the mental health wellbeing, are driving the Anxiety Disorders & Depression Treatment market. Depression has become a rapidly commonplace disorder, due to hectic lifestyle and stressed work and personal life. According to anxiety and depression association of America, depression is the leading cause of disability in the United States among people ages 15-44. It also reports that in 2017, an estimated 17.3 million aged 18 years or older had experienced at least one major depressive episode in the last year in USA, which represented 6.7 percent of all American adults. Almost 75% of people with mental disorders remain untreated in developing countries such as India and China, with almost 1 million people committing suicide. The patents of many companies operating in anxiety and depression treatment are expiring which are giving rise to use of generics. The issues of expiration of patents of branded anxiety and depression curing drugs may act as a restraint for its growth. However, increasing efforts of government to tackle mental health issues acts as an opportunity for Anxiety Disorders & Depression Treatment Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analyzed to provide a holistic picture of Anxiety Disorders & Depression Treatment Market. Due to increased awareness for depression and anxiety as well as higher per capita income, North America is the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing population living a stressed work and personal life.

Major market player included in this report are:
Pfizer Inc
GlaxoSmithKline
Merck & Co. Inc
AstraZeneca
Eli Lily & Co
Johnson & Johnson
Forest Laboratories, Inc
Sanofi-Aventis
H. Lundbeck A/S
Bristol-Myers Squibb Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Antidepressant Drugs
Therapy & Devices

By Indication:
Major Depressive Disorder (MDD)
Obsessive-Compulsive Disorder (OCD)
Phobia
Others

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Anxiety Disorders & Depression Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…